{"id":45051,"date":"2016-09-29T00:00:00","date_gmt":"2016-09-29T04:00:00","guid":{"rendered":"https:\/\/asweetlife.org\/how-jdrf-paved-the-way-for-medtronics-artificial-pancreas\/"},"modified":"2016-10-31T06:01:41","modified_gmt":"2016-10-31T10:01:41","slug":"how-jdrf-paved-the-way-for-medtronics-artificial-pancreas","status":"publish","type":"post","link":"https:\/\/asweetlife.org\/?p=45051","title":{"rendered":"How JDRF Paved the Way for Medtronic’s ‘Artificial Pancreas’"},"content":{"rendered":"

\u00a0<\/p>\n

On a February morning in 1962, astronaut John Glenn was launched into space to orbit the earth. The world watched in wonder, imagining what could be next. Man could walk on the moon; space travel could \u2013 and would \u2013 become real. The future seemed so bright and open. And it was.<\/p>\n

Yesterday, the diabetes world had a similar experience as Medtronic won approval for the very first \u201cArtificial Pancreas\u201d in the United States. Like that earth orbit, this launch is just a beginning. And like that world of watchers in 1962, the diabetes community is filled with hope, wonder, and joy.<\/p>\n

Before we go into details: a checkpoint from JDRF CEO Derek Rapp, who spoke to JDRF leaders on a call Wednesday afternoon: \u201cOur work is not done. Today is a great day, but we\u2019ve got more work to do.\u201d<\/p>\n

JDRF had reason to celebrate: it was at a board table just a decade ago that then international board member \u2013 and now Bigfoot<\/a> Founder \u2013 Jeffrey Brewer gave his own call to action. Acknowledging the long road ahead until a cure, Brewer challenged JDRF to expedite the road to better tools, specifically to what came to be called the \u201cartificial pancreas.\u201d Rapp commended Brewer today and said he\u2019d be calling to personally thank him.<\/p>\n

So where are we? \u00a0Medtronic has won USA FDA approval to market their Medtronic MiniMed 670G hybrid closed-loop system, a \u201chybrid pump\u201d.<\/a> In doing this, the FDA became the first regulator in the world to approve a commercial version of this technology. It is approved for people 14 and up, and Medtronic has plans for trials to win approval for children under that age in the near future as well. Of course, as has been the case as pumps and CGMS come to the market, patients can work with their physicians to get approval \u201coff label\u201d for those younger ages.<\/p>\n

JDRF Chief Mission Officer Aaron Kowalski, who has headed up this push, said today that Medtronic is hoping to have the system on the market by the spring of 2017, and that they do not expect the price point to be much different than their current system, the 630G.<\/p>\n

Why is this a big deal? Because, put simply, this has paved the way for similar products \u2013 by many companies \u2013 to win approval as well.<\/p>\n

Rapp said that without JDRF, this would never have happened. \u201cMake no mistake: This day would not have happened were it not for JDRF. The name on the product might not say JDRF, but our work went into making this a reality.\u201d<\/p>\n

That work started years ago when JDRF funded the first trial at Yale to prove an algorithm could work in such a system. They went on to fund more trials and also to push the FDA toward approval. The JDRF push to prioritize AP project moved the products toward the top of a very long list at the FDA a number of years ago.<\/p>\n

\u201cThis is an epic day,\u201d Kowalski said. \u201cTo see it happen after over a decade of work is amazing\u201d<\/p>\n

The hybrid system requires the user to still do mealtime boluses. But, it also turns off when it detects lowering blood sugars, and ramps up insulin doses when it detects a trend toward high. The system will use the new Medtronic pump body, a 4th generation sensor (Not the current Medtronic sensor) and a control algorithm to automate basal insulin delivery to maximize the time glucose levels are in a healthy range throughout the day and night. Previous systems stop insulin in response to existing or predicted low sensor glucose values; hybrid closed-loop systems combine user-delivered pre-meal boluses with automatic insulin delivery.<\/p>\n

JDRF is working harder now, Kowalski said, with a goal of access for all for all such products, and to continue pushing other products toward market as well.<\/p>\n

\u201cThis is not the end of the game,\u201d Kowalski, who estimates that JDRF\u2019s work and funding accelerated this process by five to seven years, said. \u201cWe want other systems, competition and ultimately, a cure. Ultimately, we want to completely eliminate the need for this system with a cure.\u201d<\/p>\n

The Medtronic system won’t be the end all, nor will it be the only one available. But the FDA approval, imagined at a table by Jeffrey Brewer only a decade ago, is reality. And just like that orbit of earth, it could very well be a most remarkable beginning.<\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

…<\/p>\n","protected":false},"author":24,"featured_media":38334,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"image","meta":{"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[1448],"tags":[],"yoast_head":"\nHow JDRF Paved the Way for Medtronic's 'Artificial Pancreas'<\/title>\n<meta name=\"description\" content=\"How JDRF Paved the Way for Medtronic's 'Artificial Pancreas'\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/asweetlife.org\/?p=45051\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Moira McCarthy\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/asweetlife.org\/?p=45051\",\"url\":\"https:\/\/asweetlife.org\/?p=45051\",\"name\":\"How JDRF Paved the Way for Medtronic's 'Artificial Pancreas'\",\"isPartOf\":{\"@id\":\"https:\/\/asweetlife.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/asweetlife.org\/?p=45051#primaryimage\"},\"image\":{\"@id\":\"https:\/\/asweetlife.org\/?p=45051#primaryimage\"},\"thumbnailUrl\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2015\/10\/JDRF-Logo.jpg\",\"datePublished\":\"2016-09-29T04:00:00+00:00\",\"dateModified\":\"2016-10-31T10:01:41+00:00\",\"author\":{\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/da9789c052843c4223a7b58094bdd156\"},\"description\":\"How JDRF Paved the Way for Medtronic's 'Artificial Pancreas'\",\"breadcrumb\":{\"@id\":\"https:\/\/asweetlife.org\/?p=45051#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/asweetlife.org\/?p=45051\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/asweetlife.org\/?p=45051#primaryimage\",\"url\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2015\/10\/JDRF-Logo.jpg\",\"contentUrl\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2015\/10\/JDRF-Logo.jpg\",\"width\":600,\"height\":400,\"caption\":\"JDRF\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/asweetlife.org\/?p=45051#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/asweetlife.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How JDRF Paved the Way for Medtronic’s ‘Artificial Pancreas’\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/asweetlife.org\/#website\",\"url\":\"https:\/\/asweetlife.org\/\",\"name\":\"ASweetLife\",\"description\":\"The Diabetes Magazine\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/asweetlife.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/da9789c052843c4223a7b58094bdd156\",\"name\":\"Moira McCarthy\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/4979fd2b2da2f47d72073190a6fc3e75?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/4979fd2b2da2f47d72073190a6fc3e75?s=96&d=mm&r=g\",\"caption\":\"Moira McCarthy\"},\"description\":\"Moira McCarthy was pursuing her dream career in active sports journalism when her young daughter was diagnosed with Type 1 Diabetes in 1997. While she continued on that route, writing for the New York Times Sports and Leisure Division, Snow Country Magazine, Ski Magazine and becoming a daily newspaper sports columnist for the Boston Herald, she also began dedicating much of her life to diabetes advocacy and education.\",\"url\":\"https:\/\/asweetlife.org\/?author=24\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How JDRF Paved the Way for Medtronic's 'Artificial Pancreas'","description":"How JDRF Paved the Way for Medtronic's 'Artificial Pancreas'","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/asweetlife.org\/?p=45051","twitter_misc":{"Written by":"Moira McCarthy","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/asweetlife.org\/?p=45051","url":"https:\/\/asweetlife.org\/?p=45051","name":"How JDRF Paved the Way for Medtronic's 'Artificial Pancreas'","isPartOf":{"@id":"https:\/\/asweetlife.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/asweetlife.org\/?p=45051#primaryimage"},"image":{"@id":"https:\/\/asweetlife.org\/?p=45051#primaryimage"},"thumbnailUrl":"https:\/\/asweetlife.org\/wp-content\/uploads\/2015\/10\/JDRF-Logo.jpg","datePublished":"2016-09-29T04:00:00+00:00","dateModified":"2016-10-31T10:01:41+00:00","author":{"@id":"https:\/\/asweetlife.org\/#\/schema\/person\/da9789c052843c4223a7b58094bdd156"},"description":"How JDRF Paved the Way for Medtronic's 'Artificial Pancreas'","breadcrumb":{"@id":"https:\/\/asweetlife.org\/?p=45051#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/asweetlife.org\/?p=45051"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/asweetlife.org\/?p=45051#primaryimage","url":"https:\/\/asweetlife.org\/wp-content\/uploads\/2015\/10\/JDRF-Logo.jpg","contentUrl":"https:\/\/asweetlife.org\/wp-content\/uploads\/2015\/10\/JDRF-Logo.jpg","width":600,"height":400,"caption":"JDRF"},{"@type":"BreadcrumbList","@id":"https:\/\/asweetlife.org\/?p=45051#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/asweetlife.org\/"},{"@type":"ListItem","position":2,"name":"How JDRF Paved the Way for Medtronic’s ‘Artificial Pancreas’"}]},{"@type":"WebSite","@id":"https:\/\/asweetlife.org\/#website","url":"https:\/\/asweetlife.org\/","name":"ASweetLife","description":"The Diabetes Magazine","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/asweetlife.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/asweetlife.org\/#\/schema\/person\/da9789c052843c4223a7b58094bdd156","name":"Moira McCarthy","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/asweetlife.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/4979fd2b2da2f47d72073190a6fc3e75?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4979fd2b2da2f47d72073190a6fc3e75?s=96&d=mm&r=g","caption":"Moira McCarthy"},"description":"Moira McCarthy was pursuing her dream career in active sports journalism when her young daughter was diagnosed with Type 1 Diabetes in 1997. While she continued on that route, writing for the New York Times Sports and Leisure Division, Snow Country Magazine, Ski Magazine and becoming a daily newspaper sports columnist for the Boston Herald, she also began dedicating much of her life to diabetes advocacy and education.","url":"https:\/\/asweetlife.org\/?author=24"}]}},"_links":{"self":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/45051"}],"collection":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=45051"}],"version-history":[{"count":1,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/45051\/revisions"}],"predecessor-version":[{"id":45129,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/45051\/revisions\/45129"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/media\/38334"}],"wp:attachment":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=45051"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=45051"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=45051"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}